A combination of plasma phospho‐tau217 and Aβ42/40 detects early development of amyloid pathology in cognitively unimpaired individuals
Shorena Janelidze, Nicolas R Barthélemy, Gemma Salvadó, Sebastian Palmqvist, Niklas Mattsson‐Carlgren, Vitaliy Ovod, James G Bollinger, Yingxin He, Suzanne E Schindler, Kaj Blennow, Erik Stomrud, Randall J Bateman, Oskar Hansson · 2025
Read A combination of plasma phospho‐tau217 and Aβ42/40 detects early development of amyloid pathology in cognitively unimpaired individuals by Shorena Janelidze, Nicolas R Barthélemy, Gemma Salvadó, Sebastian Palmqvist, Niklas Mattsson‐Carlgren, Vitaliy Ovod, James G Bollinger, Yingxin He, Suzanne E Schindler, Kaj Blennow, Erik Stomrud, Randall J Bateman, Oskar Hansson (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11715842.txt.
Description
Janelidze, Hansson and their co-authors test whether two blood markers together can flag early amyloid build-up in Alzheimer disease in 2025. Finding people at high risk before symptoms start is key for future prevention trials.
The study drew on two Swedish cohorts of cognitively healthy and impaired adults. A paired blood measure beat either marker alone at spotting abnormal spinal fluid results in healthy adults. In healthy adults with normal brain scans at first, both markers linked to later amyloid growth. A second cohort backed the same pattern using spinal fluid change, the authors report.
Catalog record
| CREATOR | Shorena Janelidze, Nicolas R Barthélemy, Gemma Salvadó, Sebastian Palmqvist, Niklas Mattsson‐Carlgren, Vitaliy Ovod, James G Bollinger, Yingxin He, Suzanne E Schindler, Kaj Blennow, Erik Stomrud, Randall J Bateman, Oskar Hansson |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |